Table 1.
Nasopharyngeal swabs |
Disease-causing |
Total |
|
---|---|---|---|
Gender |
|||
Female |
42.7 % (32/75) |
41.6 % (47/113) |
42.0 % (79) |
Male |
57.3 % (43/75) |
58.4 % (66/113) |
58.0 % (109) |
Vaccine period |
|||
Pre-PCV10 |
81.3 % (61/75) |
16.8 % (19/113) |
42.6 % (80) |
Post-PCV10 |
18.7 % (14/75) |
83.2 % (94/113) |
57.4 % (108) |
Age (years)* |
|||
≤5 |
98.7 % (74/75) |
37.5 % (42/112) |
62.0 % (116) |
>5 |
1.3 % (1/75) |
62.5 % (70/112) |
38.0 % (71) |
Province |
|||
Sindh |
81.3 % (61/75) |
33.6 % (38/113) |
52.7 % (99) |
Punjab |
18.7 % (14/75) |
54.0 % (61/113) |
39.9 % (75) |
Khyber Pakhtunkhwa |
0 |
9.7 % (11/113) |
5.9 % (11) |
Azad Jammu and Kashmir |
0 |
2.7 % (3/113) |
1.6 % (3) |
Year |
|||
2006 |
0 |
7.1 % (8/113) |
4.3 % (8) |
2007 |
0 |
1.8 % (2/113) |
1.1 % (2) |
2009 |
0 |
0.9 % (1/113) |
0.5 % (1) |
2010 |
0 |
2.7 % (3/113) |
1.6 % (3) |
2011 |
0 |
0.9 % (1/113) |
0.5 % (1) |
2012 |
0 |
0.9 % (1/113) |
0.5 % (1) |
2013 |
81.3 % (61/75) |
2.7 % (3/113) |
34.0 % (64) |
2014 |
0 |
5.3 % (6/113) |
3.2 % (6) |
2015 |
0 |
7.1 % (8/113) |
4.3 % (8) |
2016 |
1.3 % (1/75) |
19.5 % (22/113) |
12.2 % (23) |
2017 |
0 |
19.5 % (22/113) |
11.7 % (22) |
2018 |
0 |
20.4 % (23/113) |
12.2 % (23) |
2019 |
10.7 % (8/75) |
9.7 % (11/113) |
10.1 % (19) |
2020 |
6.7 % (5/75) |
1.8 % (2/113) |
3.7 % (7) |
For two isolates, information on their site of isolation, age, gender and city of sample collection was not available. These two isolates are not included in the table.
*For one isolate, information on age was missing and it was not included in the age section.